Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Immunology and Histocompatibility, |
RCV000851285 | SCV000993541 | likely pathogenic | Hereditary angioedema type 1 | criteria provided, single submitter | clinical testing | The c.1038_1052delGCTGCAGCTCTCCCA (p.Gln346_Ser350del) variant has been previously reported in association with hereditary angioedema in the literature (Speletas et al., 2015, Loules et al., 2018). It is a non-frameshift mutation that changes the protein length by the deletion of 15bp (5aa). It was detected by our laboratory in 2 male patients with C1-INH HAE Type I. It has never been detected in approximately 120000 individuals of the Exome Aggregation Consortium (ExAC), indicating that it is not a common variant. There are 4 different variants at this part of the gene that have been previously associated with the disease, two of which are nonsense [c.1036C>T (p.Gln346Ter), Verpy et al. (1996), c.1042C>T (p.Gln348Ter), Pappalardo et al. (2008), c.1046T>C (p.Leu349Pro), Grodecka et al. 2017 and c.1048T>C (p.Ser350Pro), Lopez-Lera et al. 2011]. According to ACMG Guidelines (Criteria: PM2, PM4, PP1, PP4) the variant is considered likely pathogenic. |